Search

Search Constraints

You searched for: Date 2020 Author/Creator Probst, Stephan

Search Results

1. Phase III randomized, double‐blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum‐containing regimen (RADPAC). Issue 9 (7th May 2020)